LABU, or the Direxion Daily S&P Biotech Bull 3X Shares, is an exchange-traded fund (ETF) that seeks to provide daily investment results that correspond to three times the daily performance of the S&P Biotechnology Select Industry Index. As an ETF, LABU holds a basket of stocks that are included in the S&P Biotechnology Select Industry Index.

The holdings of LABU are primarily biotechnology companies that are involved in the research, development, and production of biotechnology products, such as drugs, therapies, and medical devices. These companies operate in a variety of sub-sectors within the biotech industry, including pharmaceuticals, biopharmaceuticals, diagnostics, medical equipment and supplies, and more.

The holdings of LABU are subject to change over time, as the fund’s managers adjust the portfolio to reflect changes in the underlying index. As of March 31, 2022, the top 10 holdings of LABU were:

1. Moderna Inc. (MRNA)
2. Vertex Pharmaceuticals Inc. (VRTX)
3. Amgen Inc. (AMGN)
4. Regeneron Pharmaceuticals Inc. (REGN)
5. Gilead Sciences Inc. (GILD)
6. Biogen Inc. (BIIB)
7. Illumina Inc. (ILMN)
8. Biogen Inc. (BIIB)
9. Incyte Corp. (INCY)
10. BioMarin Pharmaceutical Inc. (BMRN)

These holdings represent a diverse range of biotech companies, each with their own unique products and services. As such, investing in LABU can provide exposure to the broader biotech industry and the potential for capital appreciation through the growth of these companies.

Investors who are interested in LABU should be aware of the risks involved, as the biotech sector can be highly volatile and subject to regulatory and political risks. Additionally, LABU is a leveraged ETF, which means that it seeks to provide amplified returns based on the daily performance of the S&P Biotechnology Select Industry Index. As such, it is a high-risk, high-reward investment option that is best suited for experienced traders who are comfortable with the volatility of the biotech sector.

In conclusion, LABU holds a basket of biotech companies that are included in the S&P Biotechnology Select Industry Index. These holdings represent a diverse range of companies operating in various sub-sectors within the biotech industry. Investing in LABU can provide exposure to the broader biotech industry and the potential for capital appreciation, but investors should be aware of the risks involved and consult with a financial advisor before making any investment decisions.

Read more here: